Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

AbbVie scores FDA approval for arthritis treatment upadacitinib

Could find it difficult to live up to Humira

- PMLiVE

Novo Nordisk shareholder revolt reaches Europe

Accused of lacking transparency over pricing pressures

Celgene building

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug

Currently in the middle of merger

- PMLiVE

Sanofi patent case win holds off generic rivals for key cancer drug

Boosts hope of increasing future sales

- PMLiVE

Leo Pharma to market AstraZeneca’s brodalumab outside Europe

Extends reach of the drug

- PMLiVE

Regeneron scores positive data in phase 3 cholesterol trial

Targets severe inherited disorder

Roche Basel Switzerland

Roche undercuts price of Bayer cancer drug after winning FDA approval

Both drugs highly effective in small subset of patients

- PMLiVE

Putting our core values into practice at the Porterhouse summer social

As a reward for all our hard work and in keeping with our core values, which include ‘family’ and ‘humour and happiness’, the teams at Porterhouse enjoy regular socials.For our...

Porterhouse Medical Group

- PMLiVE

Government to set up ‘express freight service’ for medicinal products in event of no-deal Brexit

Additional preparation to ensure continuity of supplies

- PMLiVE

US politicians round on generics firms for blocking drug pricing probe

Renews focus on increases in generic drug prices

- PMLiVE

Potential cure for Ebola following trial success

Two treatments increased rates of survival

- PMLiVE

AZ, Merck’s Lynparza scores market-expanding clinical success

Positive phase 3 findings in ovarian cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links